According to multiple sources cited by BNN Bloomberg, Coca-Cola is already in talks with Aurora Cannabis to develop cannabis-infused beverages. If this proves true, that would be a groundbreaking move that might signal the emergence of the favorite consumer brand into the marijuana sector.
However, as reported by the sources, Coca-Cola Co. is planning to create a brand of cannabis-infused beverages based on the Cannabidiol compounds of the cannabis plants. Cannabidiol or CBD is not a psychoactive component in the plant and many studies around the world concluded that the CBD has some health benefits unmet by traditional treatments, be them conventional medications or naturists therapies.
Instead of developing beverages that would give consumers that “buzz” similar to smoking marijuana, such as some alcohol industry big names tried to do, Coca-Cola and Aurora Cannabis aim to come up with some beneficial drinks to reduce inflammation, pain, and cramping.
Cannabis-infused beverages to be developed by Coca-Cola and Aurora Cannabis, some sources said
“As a rule, we do not discuss business development initiatives until they are finalized. However, we have a responsibility to our shareholders to give proper consideration to all relevant opportunities that are presented,” said Heather MacGregor from the Aurora. On the other hand, Kent Landers, a spokesman from Coca-Cola, refuse to comment about Aurora. However, he admitted, to some extent, that Coca-Cola is interested in CBD (Cannabidiol) as a possible ingredient in future drinks.
“Along with many others in the beverage industry, we are closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around the world. The space is evolving quickly. No decisions have been made at this time,” stated Ken lander for the BNN Bloomberg.
However, the use of Cannabidiol (CBD) in consumer products might be the next big thing in the market, but not right now.
“There’s a lot of interest from consumer-packaged goods, and liquor and tobacco companies to look at cannabis as a new growth vector. What’s happening is that the cannabis industry is still in its infancy and there’s not a lot of partners to dance with,” explained Martin Landry, the managing director of equity research at GMP Securities LP.